National Health Investors, Inc. (NHI) Stock Forecast
Data as of Jun 17, 2026Real Estate · Current price $70.99 (+0.34%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 20, 2026 | Omotayo Okusanya | National Bank | $85.00 | +19.7% |
| Dec 15, 2025 | Michael Lewis | Truist Financial | $83.00 | +16.9% |
| Nov 25, 2025 | John Kilichowski | Wells Fargo | $85.00 | +19.7% |
| Sep 24, 2024 | Joshua Dennerlein | Bank of America Securities | $92.00 | +29.6% |
| Aug 30, 2024 | Michael Lewis | Truist Financial | $78.00 | +9.9% |
| Apr 3, 2024 | Michael Lewis | Truist Financial | $58.00 | -18.3% |
| Mar 12, 2024 | John Kim | National Bank | $67.00 | -5.6% |
| Feb 26, 2024 | Connor Siversky | Wells Fargo | $63.00 | -11.3% |
| Dec 9, 2022 | Tayo Okusanya | National Bank | $58.00 | -18.3% |
| Apr 18, 2022 | John Kim | BMO Capital | $61.00 | -14.1% |
Top Analysts Covering NHI
NHI vs Sector & Market
| Metric | NHI | Real Estate Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.38 | 2.61 | 2.40 |
| Analyst Count | 8 | 8 | 19 |
| Target Upside | +17.1% | +49.4% | +17.1% |
| P/E Ratio | 22.90 | 25.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $69M | $70M | $72M | 2 |
| 2026-09-30 | $69M | $70M | $72M | 1 |
| 2026-12-31 | $69M | $70M | $72M | 1 |
| 2027-03-31 | $71M | $72M | $74M | 1 |
| 2027-06-30 | $71M | $72M | $73M | 1 |
| 2027-09-30 | $71M | $72M | $74M | 1 |
| 2027-12-31 | $72M | $73M | $75M | 1 |
| 2028-12-31 | $287M | $302M | $313M | 2 |
| 2029-12-31 | $289M | $304M | $315M | 1 |
| 2030-12-31 | $293M | $308M | $319M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.86 | $0.87 | $0.90 | 1 |
| 2026-09-30 | $0.84 | $0.86 | $0.89 | 1 |
| 2026-12-31 | $0.86 | $0.88 | $0.91 | 1 |
| 2027-03-31 | $0.83 | $0.85 | $0.88 | 1 |
| 2027-06-30 | $0.84 | $0.86 | $0.89 | 1 |
| 2027-09-30 | $0.86 | $0.87 | $0.90 | 1 |
| 2027-12-31 | $0.87 | $0.88 | $0.91 | 1 |
| 2028-12-31 | $3.38 | $3.61 | $3.78 | 1 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for NHI?
The consensus among 8 analysts covering National Health Investors, Inc. (NHI) is Buy with an average price target of $85.40.
What is the highest price target for NHI?
The highest price target for NHI is $92.00, set by Joshua Dennerlein at Bank of America Securities on 2024-09-24.
What is the lowest price target for NHI?
The lowest price target for NHI is $58.00, set by Tayo Okusanya at National Bank on 2022-12-09.
How many analysts cover NHI?
8 analysts have issued ratings for National Health Investors, Inc. in the past 12 months.
Is NHI a buy or sell right now?
Based on 8 analyst ratings, NHI has a consensus rating of Buy (2.38/5) with a +17.1% upside to the consensus target of $85.40.
What are the earnings estimates for NHI?
Analysts estimate NHI will report EPS of $0.87 for the period ending 2026-06-30, with revenue estimated at $70M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.